Insider Trading February 20, 2026

CME Group Director Disposes $91,770 in Shares as Company Advances New Products

Director Martin J. Gepsman sells 300 CME Class A shares while the exchange pursues expanded crypto hours, commodities contracts and Asian warehousing approvals

By Nina Shah CME
CME Group Director Disposes $91,770 in Shares as Company Advances New Products
CME

Director Martin J. Gepsman sold 300 Class A shares of CME Group Inc on February 20, 2026, for $305.9 per share, a transaction totaling $91,770. After the sale, Gepsman’s direct holdings stand at 24,999 shares. The trade occurred as the stock traded close to its 52-week high, and the company is pursuing several product and market expansions including 24/7 crypto trading, new physical warehouse approvals in Asia and novel futures contracts for rare earths and single stocks.

Key Points

  • Director Martin J. Gepsman sold 300 Class A shares on Feb. 20, 2026, at $305.9 per share, totaling $91,770; he now directly owns 24,999 shares of CME Group.
  • CME shares traded near a 52-week high of $309.35 and have returned 25% over the past year; InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value.
  • CME is advancing multiple expansions: proposed 24/7 crypto futures and options trading (pending regulatory approval), planned aluminium warehouse approvals in Taiwan and Hong Kong, development of rare earths futures for neodymium and praseodymium, and single stock futures covering 50+ major U.S. stocks.

Insider sale details

Martin J. Gepsman, a director at CME Group Inc (NASDAQ:CME), executed a sale of 300 Class A common shares on February 20, 2026, at $305.9 per share. The transaction value totaled $91,770. Following this disposition, Gepsman directly holds 24,999 shares of the company.


Share price context and valuation note

The sale took place while CME shares were trading near a 52-week high of $309.35. Over the last year the stock has delivered a 25% return. According to InvestingPro analysis cited by the firm, the stock currently appears overvalued relative to its Fair Value. Investors interested in further detail can consult CME’s Pro Research Report, one of more than 1,400 reports available on InvestingPro.


Corporate developments and product expansion

Separately from the insider transaction, CME Group disclosed a series of strategic product and market initiatives. Subject to regulatory approval, the exchange plans to extend trading hours for its cryptocurrency futures and options to a continuous 24/7 schedule beginning May 29. This follows record activity in the company’s crypto derivatives business, which reached $3 trillion in notional volume in 2025.

In addition, CME is working to expand its physical and derivatives footprint in Asia by planning approvals for aluminium warehouses in Taiwan and Hong Kong, which could broaden its storage network in the region.

The exchange is also developing a first-of-its-kind futures contract focused on rare earths - specifically neodymium and praseodymium - intended to provide hedging instruments for market participants. Further product expansion includes plans to introduce single stock futures this summer, covering over 50 major U.S. equities drawn from leading indices, including Alphabet, Meta, NVIDIA and Tesla.


Implications and positioning

These initiatives reflect an effort by CME Group to broaden its suite of tradable instruments across digital assets, metals warehousing and specialty commodity contracts. The combination of product launches and geographic expansion indicates a push to diversify trading volumes and client use cases, although valuation dynamics noted by InvestingPro suggest market pricing may already incorporate some of these prospects.


Note on scope - The article reports the insider transaction and the company announcements as described; it does not evaluate future outcomes or provide investment advice.

Risks

  • Regulatory approval is required to extend cryptocurrency futures and options trading to a 24/7 schedule - the outcome and timing remain uncertain, impacting the crypto derivatives market.
  • Plans to approve aluminium warehouses in Taiwan and Hong Kong depend on successful regulatory and operational implementation, affecting physical commodity logistics and related market participants.
  • Development and launch of novel futures contracts, including rare earths and single stock futures, carry execution and market-acceptance risks that could influence trading volumes and revenue projections for the exchange.

More from Insider Trading

Standex Director Disposes $513K in Stock as Company Posts Q2 Beat Feb 20, 2026 Sonoco Packaging Executive Disposes Small Stake as Company Outlines Multi-Year Earnings Goals Feb 20, 2026 Bank of the James President Buys $25,068 of Stock as Co-Founder Retires Feb 20, 2026 Bank of the James Director Adds $20,412 in Shares; Co-Founder Retires After Long Tenure Feb 20, 2026 Rogers Corp Director Disposes of 8,000 Shares; Stock Near Yearly High After Strong Quarter Feb 20, 2026